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Abstract
To identify regulatory molecules which play key roles in the development of obesity, we investigated the transcriptional profiles in 3T3-L1 cells
at early stage of differentiation and analyzed the promoter sequences of differentially regulated genes. One hundred and sixty-one (161) genes were
found to have significant changes in expression at the 2nd day following treatment with differentiation cocktail. Among them, 86 transcripts were
up-regulated and 75 transcripts were down-regulated. The 161 transcripts were classified into 10 categories according to their functional roles; cytoskeleton,
cell adhesion, immune, defense response, metabolism, protein modification, protein metabolism, regulation of transcription, signal transduction and
transporter. To identify transcription factors likely involved in regulating these differentially expressed genes, we analyzed the promoter sequences
of up- or –down regulated genes for the presence of transcription factor binding sites (TFBSs). Based on coincidence of regulatory sites, we have
identified candidate transcription factors (TFs), which include those previously known to be involved in adipogenesis (CREB, OCT-1 and c-Myc).
Among them, c-Myc was also identified by our microarray data. Our approach to take advantage of the resource of the human genome sequences
and the results from our microarray experiments should be validated by further studies of promoter occupancy and TF perturbation.
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Introduction*
Obesity is the most prevalent health problem in developed 
countries and is a growing problem in developing countries. It 
serves as a high risk factor for morbidity and mortality from 
metabolic disorders such as type-2 diabetes, dyslipidemia, 
hypertension, coronary heart disease, atherosclerosis and 
numerous types of cancer (Gregoire et al, 1998). Excess fat mass, 
characterizing obesity, is usually caused by excessive energy 
storage over a prolonged period of time. At the cellular level, 
increases in adipose tissue occur as the result of lipid accu-
mulation within pre-existing adipocytes or differentiation of 
vascular stromal cells within the adipose tissue into adipocytes 
(Rosen & Spiegelman, 2000).
To identify regulatory
  molecules which play key roles in the 
development of obesity, which in turn may serve as better 
therapeutic targets for obesity and related diseases, numerous 
investigations have focused on the adipocyte differentiation 
process. From these studies, adipogenic transcription factors and 
adipocyte-specific genes such as members of the CCAAT/ 
enhancer binding protein  (C/EBP), peroxisome proliferator- 
activated receptor  (PPAR) families, sterol-regulatory element 
binding proteins (SREBPs) have been identified. In addition to 
studies using traditional cloning and gene identification techni-
ques in a “gene by gene” manner, several investigations using 
microarray were performed on differentiation process of 3T3-L1 
preadipocytes into adipocyte (Soukas et al., 2001). As a result 
of these genome-wide studies, many genes associated with the 
cell cycle, DNA replication, metabolism, signal transduction, 
cytoskeleton, protein turnover and splicing factors as well as 
some genes involved in transcriptional regulation were identified 
as genes differentially regulated during adipocyte differentiation 
(Burton et al., 2002; Guo & Liao, 2000; Ron & Habener, 1992; 
Soukas et al., 2001). Despite of a mountain of gene expression 
profiles, an understanding of the complete mechanism by which 
precursor cells become adipocytes is far from complete and the 
genetic regulatory network underlying adipogenesis has not yet 
been fully understood. For example, many genes that mark the 
*This  work (M10510120001-05N1012-00110)  was  supported  by  research  grants  from  Korea  Science  and  Engineering  Foundation (KOSEF)  for  Biofoods  Research 
Program,  Ministry  of  Science  and  Technology.
§ Corresponding  Author:  Youn-Soo  Cha,  Tel.  82-63-270-3822,  Fax.  82-63-270-3854,  Email.  cha8@chonbuk.ac.kr20 Transcriptome and promoter analysis on adipogenesis
differentiated adipocyte were expressed with different kinetics 
than SREBPs, C/EBPs, and PPARs. Genes known to have a 
PPARγ  response element in its promoter, such as insulin-like 
growth factor-II, b3-adrenergic receptor and the 
phosphoenolpyruvate carboxykinase, are expressed only late in 
differentiation at day 4 and maximally at day 28, which is not 
consistent with the initial expression pattern of PPARγ (Soukas 
et al., 2001). Cytochrome c oxidase VIIIH, glucose-6-phosphate 
isomerase and phosphofructokinase I also demonstrated a similar 
pattern of expression, however, their pattern differed from the 
expression profile of the aforementioned transcription factors. 
These observations lead to the speculation that potentially many 
other regulatory networks are involved in regulating their 
expression. 
In this study, we investigated the transcriptional profiles in 
3T3-L1 cells at the early stage of differentiation and analyzed 
the promoter sequences of differentially regulated genes for 
identifying common transcription regulators. This approach 
might provide useful information to establish genetic regulatory 
network from gene expression profiles.
Materials and Methods
Materials
All tissue culture materials were purchased from Gibco (Grand 
Island, NY, U.S.A.). Insulin, dexamethasone and MIX were from 
Sigma  (St. Louis, MO, U.S.A). 
Cell culture
3T3-L1 preadipocytes (A.T.C.C., Manassas, VA, U.S.A.) were 
cultured in Dulbecco's modified Eagle's medium (DMEM) with 
10%  (v/v) foetal bovine serum  (FBS), 1%  (v/v) penicillin- 
streptomycin  (100 units/ml penicillin, 100 µg/ml streptomycin 
in 0.85% saline) and 1% (v/v) 100 M pyruvate at 37℃ in 95% 
air, 5% CO2. To induce differentiation, 2-day postconfluent 
3T3-L1 preadipocytes (day 0) were stimulated for 72 h with 0.5 
mM MIX, 0.5 M dexamethasone and 10 µg/ml insulin (MDI) 
added to DMEM/10% FBS culture medium. On day 3, the MDI 
medium was replaced with DMEM/10% FBS, which was 
changed every 2 days thereafter until analysis. 
Oil Red O staining
3T3-L1 preadipocyte and adipocyte cells were stained with Oil
 
Red O essentially as described by Ramirez-Zacarias, Castro-Munoz-
ledo,
  and Kuri-Harcuch (Ramirez-Zacarias et al., 1992). Briefly, 
the 3T3-L1 cells were fixed in 10% formalin
  for 90 min. After 
washing thoroughly with distilled water, cells
  were incubated 
with a working solution of Oil Red O for 3 h. The staining of 
lipid droplets in 3T3-L1 preadipocyte
  and adipocyte cells was 
quantified using a phase-contrast microscope
  and Image-Pro Plus 
software from Media Cybernetics  (Carlsbad,
  CA).
Quantitative analysis of intracellular triglyceride  (TG) accu-
mulation
For analysis of the intracellular TG content, the cells were 
washed with PBS and harvested using lysis buffer (50 mM Tris, 
1 mM EDTA, 1 mM beta-mercaptoehtanol, 10 mM MgCl2, 0.15 
mM NaCl, and 1 mM phenylmethylsufonyl fluoride, pH 7.5). 
Subsequent to sonicating the samples, spectroscopic quantifi-
cation of TG was performed using the enzyme coupled glycerol 
assay kit 337 (Sigma Diagnostics, Deisenhofen, Germany). The 
protein content was determined by the method of Bradford using 
bovine serum albumin (BSA) as the standard (Bradford, 1976). 
TG content was expressed as μg TG per g protein.
Microarray analysis
Mouse 10K cDNA microarray used in this study consisted of 
10,336 spots, as previously described  (Ahn  et al., 2004). It 
included 6531 transcripts from the National Institute of Aging 
(NIA), 1243 transcripts from the Brain Molecular Anatomy 
Project (BMAP), 2060 transcripts from InCyte Pharmaceuticals 
(Fremont, CA, USA), and yeast DNA and housekeeping genes 
as negative control. 
Total RNA was prepared from cells using Trizol (Invitrogen, 
Carlsbad, CA, USA). Fluorescence-labeled cDNA probes were 
prepared from 20μg of total RNA by using an amino-allyl cDNA 
labeling kit (Ambion, Austin, Texas, USA). At least four repli-
cates were performed, and two of these were repeated with the 
fluorophores reversed to eliminate false-positive results. The Cy5 
and Cy3 probes were mixed, and hybridization was performed 
at 55℃ for 16 h, as previously described (Ahn  et al., 2004). 
The two fluorescent images  (Cy3 and Cy5) were scanned 
separately by a GMS 418 Array Scanner  (Affymetrix, Santa 
Clara, CA, USA), and the image data were analyzed using 
ImaGene 4.2  (Biodiscovery, Santa Monica, CA, USA) and 
MAAS (Gaiagene, Seoul, Korea) software (Kim  et al., 2001). 
For each hybridization, emission signal data were normalized by 
multiplying the Cy3 signal values by the ratio of the means of 
the Cy3 and Cy5 signal intensities for all spots on the array. 
The criteria to eliminate unreliable data were previously 
described  (Kim  et al., 2004).
In this analysis, we calculated the median value of gene 
expression ratio from four independently repeated microarray 
experiments. We used the modified t-tests, SAM method to 
evaluate statistical significance of changes in gene expression 
(Tusher  et al., 2001). We took the genome-wide significance 
level at the SAM  (δ)=0.66 and adopted a cutoff of 2.0-fold 
change based on our experiences. Genes showing significant 
differences in expression levels were classified into different 
functional categories, based on Gene Ontology  (GO) with Su-jong Kim et al. 21
modifications. 
Real-time quantitative PCR analysis and melting curve analysis
Four micrograms of total RNA was reverse-transcribed in 25 
μl of reaction mixture, containing 2.5 U MuLV reverse 
transcriptase, 1 U RNAse inhibitor, 5 mM MgCl2, 50 mM KCl, 
10 mM Tris HCl (pH 8.3), 2.5 μM oligo (dT) primer, and 1 
mM dNTPs. The reaction mixture was heated to 42℃ for 60 
min and then denatured at 85℃ for 5 min. cDNA was amplified 
with ICycler (BioRad, Hercules, CA, USA) in 50 μl of reaction 
mixture containing AmpliTaq DNA polymerase  (0.04 U/μl, 
Perkin Elmer, Shelton, Connecticut), 50 mM Tris (pH 8.3), 3 
mM MgCl2, 0.25 mM dNTPs, 1/50,000 dilution of SYBR Green 
I  (Molecular Probes, Eugene, OR), and 0.25 μM appropriate 
sense and antisense PCR primers. The sequences of the primers 
were as follows: fatty acid synthase (Fasn) forward, 5′-TCC ACC 
TTT AAG TTG CCC TG-3′, reverse, 5′-TCT GCT CTC GTC 
ATG TCA CC-3′ aldolase1 forward, 5′-CTA CAA GGC TCT 
GAG CGA CC-3′, reverse, 5′-ACA GGA AAG TGA CCC CAG 
TG-3′ carnitine palmitoyltransferase 2 (Cpt2) forward, 5′-CAC 
AAC ATC CTG TCC ACC AG-3′, reverse, 5′-CAT TGC AGC 
CTA TCC AGT CA-3′ peroxisome proliferator-activated receptor 
γ (Pparg) forward, 5′-CAA GAC TAC CCT TTA AGT GAA-
3′, reverse, 5′-CTA CTT TGA TCG CAC TTT GGT-3′ Iroquois 
related homeobox 5 (Drosophila) (Irx5) forward, 5′-CTG TCC 
CGG CCT CTT TAT TAC A-3′, reverse, 5′-ACC GTC TGG 
TTT AAT CCA TTG A-3′ transforming growth factor, beta 3 
(Tgfb3) forward, 5′-CCT GGC CCT GCT GAA CTT G-3′, 
reverse, 5′-GAC GTG GGT CAT CAC CGA T-3′ Transforming 
growth factor, beta receptor II (Tgfbr2) 5′-CCG CTG CAT ATC 
GTC CTG TG-3′, reverse, 5′-AGT GGA TGG ATG GTC CTA 
TTA CA-3′ Mitogen-activated protein kinase 6 (Mapk6) 5′-CAT 
GGA CTT AAA ACC ATT GGG CT-3′, reverse, 5′-TGA GGA 
CAA TTT TCT TGA TGG CT-3′ Metallothionein 1 (Mt1) 5′
-AAG AGT GAG TTG GGA CAC CTT-3′, reverse, 5′-CGA 
GAC AAT ACA ATG GCC TCC-3′ Metallothionein 2  (Mt2) 
5′-GCC TGC AAA TGC AAA CAA TGC-3′, reverse, 5′-AGC 
TGC ACT TGT CGG AAG C-3′ Caveolin, caveolae protein 1 
(Cav1) 5′-ATG TCT GGG GGC AAA TAC GTG-3′, reverse, 
5′-CGC GTC ATA CAC TTG CTT CT-3′ Fatty acid binding 
protein 4, adipocyte  (Fabp4) 5′-AAG GTG AAG AGC ATC 
ATA ACC CT-3′, reverse, 5′-TCA CGC CTT TCA TAA CAC 
ATT CC-3′ Serine  (or cysteine) peptidase inhibitor, clade F, 
member 1 (Serpinf1) 5′-GCC CTG GTG CTA CTC CTC T-3′, 
reverse, 5′-CGG ATC TCA GGC GGT ACA G-3′ Serine (or 
cysteine) peptidase inhibitor, clade E, member 2 (Serpine2) 5′
-CAC ATG GGA TCG CGT CCA TC-3′, reverse, 5′-CAG CAC 
TTT ACC AAC TCC GTT TA-3′ Activating transcription factor 
4  (Atf4) 5′-ATG GCG CTC TTC ACG AAA TC-3′, reverse, 
5′-ACT GGT CGA AGG GGT CAT CAA-3′  Activating 
transcription factor 5 (Atf5) 5′-CTT CTC TGA TTG GAT GAC 
TGA GC-3′, reverse, 5′-CCT TCT TGA GTA GGG ATG CCA 
T-3′ Early growth response 1 (Egr1) 5′-GTT ATC CCA GCC 
AAA CGA CTC-3′, reverse, 5′-GGT TCA GGC CAC AAA GTG 
TT-3′ β-actin forward, 5′GGG TCA GAA GGA CTC CTA TG-
3′  reverse, 5′GTA ACA ATG CCA TGT TCA AT-3′  The 
following cycling conditions were used: one denaturing cycle at 
95℃ for 5 min, followed by 30 cycles of 95℃ for 30 s, 60℃ 
for 45 s, and 72℃  for 1 min. Relative RNA levels were 
determined by analyzing the changes in SYBR Green I 
fluorescence during PCR according to the manufacturer's 
instructions.  β-actin was amplified in parallel and the results 
were used for normalization. The correct size of PCR product 
was confirmed by electrophoresis on a 2% agarose gel stained 
with ethidium bromide. Purity of the amplified PCR products 
was determined by melting point analysis using the ICycler 
software.
Promoter analysis 
Promoter analysis was performed using PAINT v3.0 as 
previously described (Addya et al., 2004). PAINT v3.0 contains 
a database of promoters (UpstreamDB) constructed for all the 
annotated genes (known and putative) in the Ensembl genome 
database for Mus musculus, containing 24,261 genes (Clamp et 
al., 2003). Promoter analysis for putative TREs, i.e., binding sites 
for known transcription factors (TFs) was performed by MATCH 
tool using TRANSFAC database version 7.2. For each gene, 
2,000 base pairs (bp) upstream (5’ to the transcription start site) 
were analyzed. For each group of genes analyzed, the P values 
for significance of enrichment of each TRE in that group were 
calculated using hypergeometric distribution, by comparing the 
abundance of each TRE to that from a reference set of randomly 
selected genes.
Results
Histological and biochemical analysis of adipocyte differen-
tiation
The 3T3-L1 preadipocytes differentiated to adipocytes in 
response to the administration of dexamethasone, indomethacin, 
3-isobutyl-1-methyl-xanthine, and insulin as previously described 
(Pittenger  et al., 1999). As shown in Fig. 1(a), a few cells 
accumulating lipid vesicles were observed at the 2nd day 
following stimulation, and then the lipid droplet-containing cell 
population was increased in a time-dependent manner up to day 
6. Accumulation of triglycerides in cells was also increased in 
a time-dependent manner up to day 6  (Fig. 1(b)).
Identification of genes differentially regulated during 3T3-L1 
preadipocyte differentiation
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Fig. 1. Histological and biochemical analysis of adipocyte differentation
Post-confluent 3T3-L1 cells were hormonally treated with differentiation cocktail (1μ
M dexamethasone, 5 μ g/ml insulin, and 0.5 mM IBMX) for 6 days as described 
in the Methods section. (a) The cells were fixed at the indicated time points and 
stained  with  Oil  Red  O  to  assess  lipid  accumulation (100X  magnification). (b) (c) 
D ata of triglycerid es and p rotein are exp ressed as m ean±S.D (n = 3). Asterisks 
denote  significant  difference  ( A N O V A )  b e t w e e n  t h e  c o n t r o l  a n d  d i f f e r e n t i a t i o n  
cocktail  treatment  on  days  2,  4  and  6 (p＜0.05).
(a) MA plots
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Fig. 2. Representative MA plots and SAM plot
(a)  Representative  MA  plots  comparing  the  3T3-L1  preadpocytes  vs.  the 
differentiated cells. M represents the log ratio of the two fluorescent dyes used to
label probes, and A represents averaged logarithmic intensity. Broken line represents
a  2-fold  change.  (b)  SAM  scatter  plot  of  observed  relative  difference  versus  the 
expected relative difference. The genes showing significant difference in expression
between the 3T3-L1 preadpocytes and the differentiated cells were identified. Broken
line  represents  δ=  0.66.
Fig. 3. Global gene expression profile in functional categories
Black  bars  and  white  bars  represent  the  percentage  of  induced  and  repressed 
genes,  respectively. 
preadipocyte differentiation, about 10,000 gene expression levels 
in differentiation cocktail treated 3T3-L1 cells were compared 
with those of vehicle-treated cells as control. Only the genes, 
whose mRNA levels were changed 2.0-fold or higher and 
detected as significant change by SAM method, were designated 
as differentially expressed genes (Fig. 2). By these criteria, 161 
genes were found to have significant changes in expression at 
the 2nd day following treatment with differentiation cocktail 
(Table 1, 2). Of these 161 transcripts, 86 transcripts were up- 
regulated and 75 transcripts were down-regulated. The 161 
transcripts were classified into 10 categories according to their 
functional roles: cytoskeleton, cell adhesion, immunity, defense 
response, metabolism, protein modification, protein metabolism, 
regulation of transcription, signal transduction and transporter 
(Fig. 3).
Verification of the microarray results with Real-time RT PCR
To validate the differential gene expression revealed by cDNA 
microarray-based profiling of 3T3-L1 adipogenesis, real-time 
quantitative RT-PCR was carried out for several selected genes; 
fatty acid synthase  (Fasn), aldolase1, carnitine palmitoyltrans-
ferase 2  (Cpt2), peroxisome proliferator-activated receptorγ 
(Pparg), Iroquois related homeobox 5  (Drosophila)  (Irx5), 
transforming growth factor, beta 3 (Tgfb3), Transforming growth 
factor, beta receptor II (Tgfbr2), Mitogen-activated protein kinase 
6  (Mapk6), Metallothionein 1  (Mt1), Metallothionein 2  (Mt2), 
Caveolin, caveolae protein 1 (Cav1), Fatty acid binding protein 
4, adipocyte  (Fabp4), Serine  (or cysteine) peptidase inhibitor, Su-jong Kim et al. 23
Table 1. Genes which were upregulated during adipogenesis
Genebank 
number Gene name Symbol Fold 
change
Cytoskeleton and cell adhesion
AI849746 Talin 1 Tln1 2.2
BG084556 Myosin Vb Myo5b 2.3
W67022 Keratin complex 1, acidic, gene 10 Krt1-10 2.9
BG069796 Kelch-like 2, Mayven (Drosophila) Klhl2 2.9
AI844265 Integrin beta 1 binding protein 1 Itgb1bp1 3.0
BE948546 Glycoprotein 5 (platelet) Gp5 2.7
BG086102 Chondroitin sulfate proteoglycan 2 Cspg2 2.3
Immune and defense response
AI852793 Superoxide dismutase 2, mitochondrial Sod2 2.2
W09930 Lipopolysaccharide binding protein Lbp 2.3
AW494715 Interferon activated gene 203 Ifi203 2.1
AA152885 Chemokine (C-X-C motif) ligand 13 Cxcl13 4.6
Metabolism
BG075608 Triosephosphate isomerase 1 Tpi1 2.2
BG075934 Transaldolase 1 Taldo1 2.3
BG086835 Sterol carrier protein 2, liver Scp2 2.2
AI853169 Stearoyl-Coenzyme A desaturase 1 Scd1 6.1
BG065475 S-adenosylhomocysteine hydrolase Ahcy 2.2
BG078664 Pyruvate kinase, muscle Pkm2 2.8
AA038254 Pyruvate carboxylase Pcx 3.2
BG064823 Phosphoglycerate mutase 1 Pgam1 2.3
AI850456 NAD(P) dependent steroid 
dehydrogenase-like
Nsdhl 2.0
BG075331 Myo-inositol 1-phosphate synthase A1 Isyna1 2.8
AW494998 Lipase, hormone sensitive Lipe 2.1
AI835385 Lactate dehydrogenase A Ldha 3.9
BG076460 Glutamate-cysteine ligase, catalytic 
subunit
Gclc 3.3
AI835583 Glutamate-ammonia ligase (glutamine 
synthetase)
Glul 9.2
AA011759 Glutamate-ammonia ligase (glutamine 
synthetase)
Glul 3.6
BG077710 Galactose-4-epimerase, UDP Gale 2.1
AA116513 Fatty acid synthase Fasn 3.6
W11965 Enolase 3, beta muscle Eno3 2.2
AI847556 Diacylglycerol O-acyltransferase 2 Dgat2 4.8
AI605638 Diacylglycerol O-acyltransferase 1 Dgat1 2.1
BG071627 DDHD domain containing 1 Ddhd1 2.1
BG085333 Carnitine palmitoyltransferase 2 Cpt2 2.4
AA518639 Aldolase 1, A isoform Aldoa 2.4
BG074754 Acyl-CoA synthetase long-chain family 
member 1
Acsl1 2.1
Protein modification and metabolism
AA276457 Renin 1 structural Ren1 2.1
BG062950 Prolyl endopeptidase Prep 2.7
BG087373 FK506 binding protein 5 Fkbp5 3.2
AA259979 Angiotensinogen (serpin peptidase 
inhibitor, clade A, member 8)
Agt 2.8
Regulation of transcription
AI843911 TSC22 domain family 3 Tsc22d3 4.7
AA511029 Peroxisome proliferator activated receptor 
gamma
Pparg 3.1
AA267605 Peroxisome proliferator activated receptor 
gamma
Pparg 2.7
BG078091 NMDA receptor-regulated gene 1 Narg1 2.5
AA009268 Myelocytomatosis oncogene Myc 2.5
AW492717 Iroquois related homeobox 5 (Drosophila) Irx5 4.8
BE944401 Forkhead box B2 Foxb2 3.9
AI843304 CCAAT/enhancer binding protein 
(C/EBP), alpha
Cebpa 3.0
BG064727 Alpha thalassemia/mental retardation 
syndrome X-linked homolog (human)
Atrx 2.6
Signal transduction
AI509976 Transforming growth factor, beta receptor III Tgfbr3 2.2
BG085088 Transforming growth factor, beta receptor II Tgfbr2 2.2
AI849214 Transforming growth factor, beta 3 Tgfb3 3.5
BG065450 Sorbin and SH3 domain containing 1 Sorbs1 3.2
BG080390 Regulator of G-protein signaling 2 Rgs2 6.2
AI850306 Receptor (calcitonin) activity modifying 
protein 3
Ramp3 2.0
BG069499 PTK2 protein tyrosine kinase 2 Ptk2 2.1
AU021253 Protein phosphatase 1A, magnesium 
dependent, alpha isoform
Ppm1a 2.2
BG072253 Mitogen-activated protein kinase 6 Mapk6 2.2
BG063925 Metallothionein 2 Mt2 3.0
AI427514 Metallothionein 1 Mt1 2.3
BG084827 Insulin-like growth factor binding protein 4 Igfbp4 3.5
BG088548 Growth arrest specific 6 Gas6 3.2
BE943948 Extra cellular link domain-containing 1 Xlkd1 3.1
AA466094 Cell death-inducing DFFA-like effector c Cidec 3.2
AA138693 Caveolin, caveolae protein 1 Cav1 2.1
W13905 Angiopoietin-like 4 Angptl4 3.4
AA106031 A kinase (PRKA) anchor protein 4 Akap4 3.6
Transporter
AA260521 Uncoupling protein 2 (mitochondrial, 
proton carrier)
Ucp2 2.4
AA137517 Syntaxin binding protein 2 Stxbp2 2.2
BG070928 Solute carrier family 1 (neutral amino acid 
transporter), member 5
Slc1a5 2.4
AW121314 NTF2-related export protein 1 Nxt1 2.0
AA087193 Lipocalin 2 Lcn2 11.4
AA213017 Flavin containing monooxygenase 3 Fmo3 2.6
BE943530 Fatty acid binding protein 4, adipocyte Fabp4 19.0
BG073601 Diazepam binding inhibitor Dbi 2.1
BG078810 Cytochrome c, somatic Cycs 2.5
BG063100 Cytochrome c, somatic Cycs 2.2
Unknown
BG087501 Zinc finger CCHC-type and RNA binding 
motif 1
Zcrb1 2.2
AI850717 Transcribed locus 2.4
BG071626 Similar to Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH)
LOC382450 2.8
AA122891 Similar to glyceraldehyde-3-phosphate 
dehydrogenase
LOC380687 2.5
AA137748 RIKEN cDNA 1500003O03 gene 1500003O03
Rik
2.2
BG088778 Microsomal glutathione S-transferase 3 Mgst3 2.5
AI844280 Lymphocyte antigen 6 complex, locus A Ly6a 4.3
W83922 Leucine-rich repeats and 
immunoglobulin-like domains 1
Lrig1 2.3
BG065088 DEAD (Asp-Glu-Ala-Asp) box polypeptide 
21
Ddx21 2.3
BG065476 CDNA sequence AK190093 AK190093 2.3
BG065432 ATP-binding cassette, sub-family F 
(GCN20), member 3
Abcf3 2.524 Transcriptome and promoter analysis on adipogenesis
Table 2. Genes which were downregulated during adipogenesis
Genebank 
number Gene name Symbol Fold 
change
Cytoskeleton and cell adhesion
AA423149 Cysteine rich protein 61 Cyr61 -2.5 
AA108928 Secreted phosphoprotein 1 Spp1 -3.1 
BE947634 Vascular cell adhesion molecule 1 Vcam1 -3.0 
BG087410 CD9 antigen Cd9 -2.2 
AI838607 Thrombospondin 1 Thbs1 -3.4 
AA003904 Thrombospondin 2 Thbs2 -2.6 
AI323131 Thrombospondin 3 Thbs3 -2.5 
BG077878 Caldesmon 1 Cald1 -2.4 
W64636 Calponin 1 Cnn1 -2.1 
AA220193 Calponin 2 Cnn2 -3.8 
W09925 Filamin C, gamma (actin binding protein 
280)
Flnc -2.0 
AW557788 Filamin, alpha Flna -2.2 
W96914 Lysyl oxidase Lox -3.8 
BG087143 Microfibrillar-associated protein 2 Mfap2 -2.1 
BG087200 Myosin, light polypeptide 6, alkali, 
smooth muscle and non-muscle
Myl6 -2.1 
W81878 Periostin, osteoblast specific factor Postn -2.0 
BG087142 Procollagen, type I, alpha 2 Col1a2 -4.3 
W89883 Procollagen, type III, alpha 1 Col3a1 -2.6 
AA034564 Procollagen, type V, alpha 2 Col5a2 -2.5 
AI894006 Procollagen, type XI, alpha 1 Col11a1 -2.4 
BG064802 Secreted acidic cysteine rich 
glycoprotein
Sparc -2.6 
AI835403 Thymosin, beta 4, X chromosome Tmsb4x -2.5 
AA444490 Tissue inhibitor of metalloproteinase 2 Timp2 -2.5 
BG086016 Tropomyosin 1, alpha Tpm1 -2.7 
Immune and defense response
AA213167 Heme oxygenase  (decycling) 1 Hmox1 -2.5 
AI846176 Histocompatibility 2, D region locus 1 H2-D1 -2.5 
AA033050 Serine (or cysteine) peptidase inhibitor, 
clade E, member 2
Serpine2 -2.6 
BG087320 Serine (or cysteine) peptidase inhibitor, 
clade F, member 1
Serpinf1 -5.2 
BG086364 Serine (or cysteine) peptidase inhibitor, 
clade H, member 1
Serpinh1 -2.1 
AA109951 Beta-2 microglobulin B2m -5.4 
BG087171 Complement component 1, r 
subcomponent
C1r -2.6 
BG069444 Complement component 1, s 
subcomponent
C1s -2.1 
Metabolism
BG074397 Glutathione S-transferase, mu 1 Gstm1 -2.1 
BG064825 Hexosaminidase A Hexa -2.1 
BG069782 Hydroxysteroid (17-beta) dehydrogenase 4 Hsd17b4 -2.5 
BG071742 N-acylsphingosine amidohydrolase 1 Asah1 -3.1 
AA060268 Phospholipase D family, member 3 Pld3 -2.3 
BG076063 Phosphorylase kinase alpha 2 Phka2 -2.5 
Protein modification and metabolism
W78651 Cystatin C Cst3 -2.4 
BG074453 Lysosomal membrane glycoprotein 2 Lamp2 -2.0 
AA119072 Tripeptidyl peptidase I Tpp1 -2.1 
AI836324 Carboxypeptidase E Cpe -2.4 
W14837 Legumain Lgmn -2.2 
BG087474 Procollagen C-endopeptidase enhancer 
protein
Pcolce -2.0 
Regulation of transcription
AF252627 Activating transcription factor 4 Atf4 -2.1 
AI851042 Activating transcription factor 5 Atf5 -2.2 
AA178779 Interferon regulatory factor 8 Irf8 -3.4 
AA059930 Nuclear factor I/B Nfib -2.3 
W14113 Twist gene homolog 1 (Drosophila) Twist1 -3.4 
BG070825 Early growth response 1 Egr1 -2.3 
AA023645 Four and a half LIM domains 2 Fhl2 -3.7 
Signal transduction
AA000945 DNA segment, human D4S114 D0H4S114 -4.2 
BG065503 Integrin beta 5 Itgb5 -2.9 
AI836468 Myristoylated alanine rich protein kinase 
C substrate
Marcks -3.4 
BG063995 Natriuretic peptide precursor type B Nppb -3.2 
W42321 Pentraxin related gene Ptx3 -2.5 
AA049699 Pleiotrophin Ptn -9.3 
AA038395 Ras suppressor protein 1 Rsu1 -2.4 
AI848233 Sprouty homolog 2  (Drosophila) Spry2 -2.0 
AI840211 A kinase  (PRKA) anchor protein 8-like Akap8l -2.8 
Transporter
BG076932 Annexin A1 Anxa1 -2.9 
AA002439 Annexin A5 Anxa5 -3.1 
AA499296 Annexin A6 Anxa6 -2.2 
AI837042 Apolipoprotein D Apod -2.5 
AA498131 Aquaporin 8 Aqp8 -2.3 
AU022767 Exportin 4 Xpo4 -2.1 
BG074498 Thiosulfate sulfurtransferase, 
mitochondrial
Tst -2.0 
BG085465 Nucleoredoxin Nxn -2.0 
Unknown
BG065334 0 day neonate cerebellum cDNA, RIKEN 
full-length enriched library, clone: 
C230070N19 product:myristoylated 
alanine rich protein kinase C substrate
-3.2 
AA407811 Delta-like 1 homolog  (Drosophila) Dlk1 -3.3 
W18828 Dihydropyrimidinase-like 3 Dpysl3 -2.5 
AA250039 Lectin, galactose binding, soluble 9 Lgals9 -2.1 
W82141 Lysosomal membrane glycoprotein 1 Lamp1 -2.1 
AI836519 Myeloid/lymphoid or mixed-lineage 
leukemia (trithorax homolog, 
Drosophila); translocated to, 11
Mllt11 -3.6 
AI894053 Reticulocalbin 1 Rcn1 -2.7 
clade F, member 1  (Serpinf1), Serine  (or cysteine) peptidase 
inhibitor, clade E, member 2 (Serpine2), Activating transcription 
factor 4 (Atf4), Activating transcription factor 5 (Atf5) and Early 
growth response 1 (Egr1). These genes were chosen from the 
metabolism, transcriptional regulation, signal transduction and 
protein modification categories based on the GO terms because 
these cellular processes have been reported to be important in 
adipogenesis (Gregoire et al., 1998; Heath et al., 2000; Ntambi 
& Kim, 2000; Rosen et al., 2000; Soukas et al., 2001; Yoon 
et al., 2001). The expressions of Fasn and Cpt2 involved in 
metabolism were increased by 4.6- and 2.4-fold during adipocyte 
differentiation, respectively. Transcription factors, Pparg and 
Irx5 were also increased by 3.5- and 4.2-fold. Several genes that 
play roles in signal transduction and transport also showed 
expression patterns similar to those described above Tgfb3 Su-jong Kim et al. 25
(a)
(b)
Fig. 4. Comparison between cDNA microarray analysis and real time RT-PCR
3T3-L1 cells were treated with differentiation cocktail for two days and total RNA 
was  isolated.  The  relative  mRNA  expression  levels  of  genes  were  measured  by 
real-time RT-PCR analysis with SYBRO green. Data are expressed as fold changes
(means ± SD), normalized to β-actin mRNA expression, where the values for the 
3T3-L1 preadipocytes were set at 1.00. The analyses were performed in triplicate.
Table 3. Statistically over-represented TF binding sites in the genes 
differentially expressed during adipogenesis
TFs p-value
TFs overrepresented in the promoters of the upregulated genes
AP-1/V$AP1_Q4 0.00206
HEN1/V$HEN1_01 0.03719
HEN1/V$HEN1_02 0.01779
NF-kappaB (p65)/V$NFKAPPAB65_01 0.02393
NF-kappaB/V$NFKAPPAB_01 0.04667
Oct-1/V$OCT1_07 0.03527
c-Myc/Max/V$MYCMAX_02 0.01402
c-Rel/V$CREL_01 0.0125
TFs overrepresented in the promoters of the downregulated genes
Tax/CREB/V$TAXCREB_01 0.04228
v-Myb/V$VMYB_01 0.03555
(a) Selected TFBSs from upregulated genes 
(b) Selected TFBSs from downregulated genes 
Fig. 5. Matrix of genes differentially expressed during adipogenesis and TF 
binding sites statistically over-represented in their promoters. 
(3.5-fold),  Tgfbr2  (2.2-fold),  Mapk6  (2.2-fold), Mt1  (1.7-fold) 
Mt2 (3.3-fold), Cav1 (2.1-fold) and Fabp4 (27-fold). On the other 
hand,  Serpinf1, Serpine2,  Atf4,  Atf5 and Egr1 were decreased 
after treatment with differentiation cocktail by 28, 19, 28, 40, 
and 35%  (Fig. 4). 
In general, when gene expression profiles obtained by both 
microarray analysis and RT-PCR were compared, their patterns 
were very similar with regards to the direction (up- or down- 
regulation) and degree of differences in expression. These 
observations confirmed that the microarray data were reliable.
Promoter analysis 
Promoter analysis was performed for the up- or down-regulated 
genes using PAINT v3.0 to identify biologically relevant 
transcription factor binding sites or TFBSs, found in the 
regulatory regions of these genes. For each gene differentially 
expressed during adipocyte differentiation, the regions which fell 
within 2000 base pairs (bp) upstream of the transcription start 
site (TSS) were analyzed. Table 3 shows TFBSs overrepresented 
in the promoters of the up- or down-regulated genes and P-values. 
We adopted P-value cutoff of 0.05 to select over-represented 
TFBSs. The binding sites of AP-1, HEN1, NF-kappaB  (p65), 
NF-kappaB, Oct-1, c-Myc-Max and c-Rel were selected as 
over-represented TFBSs for genes increased during adipocyte 
differentiation. NGFI-C, Tax/CREB and v-Myb binding sites 
were selected as over-represented TFBSs for genes decreased 
during adipogenesis  (Table 3, Fig. 5).
Discussion
Differentiation toward adipocytes in differentiation cocktail- 
treated 3T3-L1 cells was evidenced by lipid accumulation in the 
cells coupled with up-regulation in mRNAs characteristic of 
adipocytes [Lipase, hormone sensitive (Lipe), Fatty acid synthase 
(Fasn), Pparg, and CCAAT/enhancer binding protein (C/EBP), 
alpha (Cebpa)] (Gregoire et al., 1998; Heath et al., 2000; Ntambi 
& Kim, 2000; Rosen et al., 2000; Soukas et al., 2001; Yoon 
et al., 2001).26 Transcriptome and promoter analysis on adipogenesis
At the early differentiation stage, genes involved in cyto-
skeleton and cell adhesion were affected. Talin 1 (Tln1), Myosin 
Vb  (Myo5b), Keratin complex 1, acidic, gene 10  (Krt1-10), 
Kelch-like 2, Mayven  (Drosophila)  (Klhl2), Integrin beta 1 
binding protein 1 (Itgb1bp1), Glycoprotein 5 (platelet) (Gp5) and 
Chondroitin sulfate proteoglycan 2  (Cspg2) were up-regulated 
over 2-fold. Otherwise, Thrombospondin 1, 2, and 3, Caldesmon 
1, Calponin 1 and 2, Procollagen I, III, V, and XI, and tissue 
inhibitor of metalloproteinase 2  (Timp2) were down-regulated 
over 2-fold during early adipogenesis. The differentiation of 
3T3-L1 cells involves a dramatic alteration in cell morphology 
from a flattened fibroblast to a spherical adipocyte. Therefore, 
dynamic changes in expression of genes involved in cytoskeleton 
and cell adhesion are not unexpected during the differentiation 
process.
Genes associated with immune and defense response were also 
differentially regulated; Superoxide dismutase 2, mitochondrial 
(Sod2), Lipopolysaccharide binding protein  (Lbp), Interferon 
activated gene 203 (Ifi203) and Chemokine (C-X-C motif) ligand 
13 (Cxcl13) increased over 2-fold. Heme oxygenase (decycling) 
1(Hmox1), Histocompatibility 2, D region locus 1  (H2-D1), 
Serine  (or cysteine) peptidase inhibitor, clade E, member 2 
(Serpine2), Serine  (or cysteine) peptidase inhibitor, clade F, 
member 1  (Serpinf1), Serine  (or cysteine) peptidase inhibitor, 
clade H, member 1  (Serpinh1), Beta-2 microglobulin  (B2m), 
Complement component 1, r subcomponent (C1r) and Comple-
ment component 1, s subcomponent  (C1s) decreased. 
Genes involved in metabolism, such as Triosephosphate iso-
merase 1 (Tpi1), Transaldolase 1 (Taldo1), Sterol carrier protein 
2, liver  (Scp2), Stearoyl-Coenzyme A desaturase 1  (Scd1), 
Pyruvate kinase, muscle  (Pkm2), Pyruvate carboxylase  (Pcx), 
Phosphoglycerate mutase 1 (Pgam1), NAD(P) dependent steroid 
dehydrogenase-like (Nsdhl), Myo-inositol 1-phosphate synthase 
A1 (Isyna1), Glutamate-cysteine ligase, catalytic subunit (Gclc), 
Diacylglycerol O- acyltransferase 1 and 2  (Dgat1, Dgat2), 
carnitine palmitoyltransferase 2 (Cpt2) and acyl-CoA synthetase 
long-chain family member 1 (Acsl1), showed increased expre-
ssion patterns. Increase in expression levels of Scd1, Pcx, Lipe, 
Fasn  and Pparg genes is consistent with the previous reports 
(Heath  et al., 2000; Soukas et al., 2001).
In addition to Pparg and Cebpa mentioned above, 13 genes 
involved in regulation of transcription were affected during early 
adipogenesis; TSC22 domain family 3  (Tsc22d3), NMDA 
receptor-regulated gene 1 (Narg1), Myelocytomatosis oncogene 
(Myc), Iroquois related homeobox 5 (Drosophila) (Irx5), Fork-
head box B2  (Foxb2), Alpha thalassemia/mental retardation 
syndrome X-linked homolog (human) (Atrx) were up regulated 
over 2.0-fold. Increases in gene expression and activities of 
Pparg, Cebpa and Myc have been known to induce many 
lipogenic genes and their regulators playing pivotal roles in 
adipogenesis  (Heath  et al., 2000; Pulverer et al., 2000). 
Activating transcription factor 4 and 5  (Atf4, Atf5), Interferon 
regulatory factor 8 (Irf8), Nuclear factor I/B (Nfib), Twist gene 
homolog 1 (Drosophila) (Twist1), Early growth response 1 (Egr1) 
and Four and a half LIM domains 2 (Fhl2) were down-regulated 
over 2-fold. Activating transcription factor 2 was previously 
shown to be decreased during adipogenesis (Burton et al., 2004). 
The roles of transcription factors previously unappreciated in the 
generation of differentiated adipocytes remain to be determined.
Many genes involved in signal transduction exhibit dynamic 
changes in expression. One of the most interesting results was 
that genes in the transforming growth factor, beta (TGFβ) signal 
pathway were expressed an average 2.5-fold higher in the 3T3-L1 
cells at the early differentiation. Transforming growth factor, beta 
3 (Tgfb3), and transforming growth factor beta receptor II and 
III (Tgfbr2, Tgfbr3 ) were increased by 2.5-, 1.2 and 1.2-fold 
during adipocyte differentiation. Regulator of G-protein signaling 
2 (Rgs2) (up-regulated by 5.2-fold), Metallothionein 1 and 2 (Mt1 
and Mt2) (up-regulated by 1.3- and 2.0-fold), Insulin-like growth 
factor binding protein 4  (Igfbp4)  (up-regulated by 2.5-fold) 
showed similar expression patterns. Rgs2 was previously isolated 
as a gene which is induced at the earliest stage of adipocyte 
differentiation (Imagawa  et al., 1999; Nishizuka et al., 2001). 
Induction of Rgs2 was stage-specific, occurring in the confluent 
cells but not in the proliferating cells, indicating that the 
expression of Rgs2 is closely related to adipocyte differentiation. 
MTs are also induced in 3T3-L1 mouse fibroblasts during 
adipocyte differentiation and suggested to play a role in adipocyte 
differentiation (Schmidt & Beyersmann, 1999; Traythurn et al., 
2000a; Traythurn et al., 2000b). The level of MT-2A mRNA 
in subcutaneous fat tissues was found to be significantly higher 
in obese subjects (Do et al., 2000). Our results were consistent 
with these previous reports. 
Genes coding for transporter proteins were also affected. Fatty 
acid binding protein 4  (Fabp4), adipocyte increased  (18-fold) 
during adipogenesis, as previously reported (Burton et al., 2004). 
Annexin A5 was decreased by -2.1-fold, which is consistent with 
a previous report  (Burton  et al., 2004).
Regulatory regions in promoters of differentially expressed 
genes provide insight into potential coordinate regulation of gene 
expression. PAINT analysis identified binding sites for tran-
scription factors known to serve important roles in cell proli-
feration, differentiation and developmental processes in other 
systems; AP-1, HEN1, NF-kappaB family, Oct-1, c-Myc/Max, 
Tax/CREB, and v-Myb. Rapid and transient induction of AP-1 
was shown during the conversion of 3T3-L1 cells to adipocytes 
(Ishida  et al., 1988). Up-regulation of c-Myc during adipose 
differentiation was observed in our microarray analysis. In 
addition, increases in gene expression and activities of Myc have 
been shown in previous studies (Heath et al., 2000; Pulverer et 
al., 2000). Adipogenesis is associated with changes in amount 
and subunit composition of the NF-kB complexes. NF-kB 
subunits p65  (RelA), p68  (RelB), and IkB were shown to be 
up-regulated during fat cell differentiation. Correspondingly, 
basal NF-kB nuclear gel shift and luciferase reporter assays were 
also shown to be induced in parallel during differentiation (Berg Su-jong Kim et al. 27
et al., 2004). Oct-1 was shown to be involved in TNFα-induced 
decreases in adipocytes differentiation and LPL gene transcri-
ption  (Morin  et al., 1995).
It is noteworthy that TFBS for HEN1 not known to be 
expressed during adipocyte differentiation were found to be 
significantly enriched in this promoter analysis  (see Table 3).
HEN1 was originally discovered because of its homology 
within the bHLH motif to the hematopoietic transcription factor 
and oncogene SCL (Begley  et al., 1992). HEN1 expression is 
confined to the nervous system, and has been observed to be 
induced throughout embryonic development  (Begley  et al., 
1992). The roles of HEN1 in the generation of differentiated 
adipocytes remain to be determined.
In summary, we investigated the transcriptional profiles in 
3T3-L1 cells at early stage of differentiation and analyzed the 
promoters of differentially regulated genes using bioinformatics. 
This information will be useful for establishing the regulatory 
network among genes involved in adipogenesis. Further studies 
of promoter occupancy and transcription factor perturbation are 
now required to provide a functional validation of the TFBSs 
identified in this study, as well as the TFs that bind to them.
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